MF

Mehnaz Fatima

Active Director Director DIN 10439288
DIN 10439288 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Mehnaz Fatima

Data last updated:

Mehnaz Fatima is a Director at Medexiq Healthcare Private Limited (since 2023). Medexiq Healthcare Private Limited reported revenue of ₹15.6 Lakh (FY 2025).

DIN 10439288
Primary Designation Director
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs
Largest company Medexiq Healthcare Private Limited · ₹15.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medexiq Healthcare Private Limited U86100JK2023PTC015411
Director26 Dec 20232023₹15.6 Lakh (FY 2025)Active

Board colleagues of Mehnaz Fatima

NameDINCompanyDesignation
Muzamil Ahmad Beig10439289Medexiq Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medexiq Healthcare Private Limited
Premium access

Shareholding and investment profile for Mehnaz Fatima

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehnaz Fatima

Mehnaz Fatima currently holds 1 directorship: Medexiq Healthcare Private Limited (Director, since 26 Dec 2023, revenue ₹15.6 Lakh (FY 2025)).

Mehnaz Fatima was first appointed on 26 Dec 2023 as Director at Medexiq Healthcare Private Limited.

The current boards of Mehnaz Fatima's companies include Muzamil Ahmad Beig (Medexiq Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available